SAN ANTONIO (EGMN) - Fewer than one in five women with metastatic breast cancer have ever participated in a clinical trial, according to a large international survey. The No. 1 reason these women with incurable cancer cited for not participating in clinical trials that aimed at finding sorely needed new treatments was that their primary physician hadn't recommended it, Catherine Glennon, R.N., reported at the San Antonio Breast Cancer Symposium.Conversely, among the 18% of surveyed metastatic breast...